International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Minimizing the Risk of Teratogenic Substance Exposure for Pregnant Compounding Pharmacists

Author(s): Paoletti James E, Benavides Tomas J

Issue: Nov/Dec 1998 - Environmental Compounds
View All Articles in Issue

Page(s): 414-415

Minimizing the Risk of Teratogenic Substance Exposure for Pregnant Compounding Pharmacists Page 1

Minimizing the Risk of Teratogenic Substance Exposure for Pregnant Compounding Pharmacists Page 2

Download in electronic PDF format for $75

Abstract: The handling of chemicals in the compounding lab by a pregnant woman presents a unique problem. Proper mask, gown and gloves should be worn any time a pregnant woman enters the lab or cleanroom. Chemical agents known or thought to possibly cause fetal damage must be completely avoided by pregnant lab personnel. The authors include a list of known or suspected teratogenic substances (not all inclusive).

Related Keywords: Anticonvulsants, Antitussives, Analgesics, Anticoagulants, Diuretics, Antihypertensives, Antidirrheals

Related Categories: CANCER AND AIDS, SUPPORT

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Minimizing the Risk of Teratogenic Substance Exposure for Pregnant Compounding Pharmacists Paoletti James E, Benavides Tomas J	Nov/Dec 1998 Pg. 414-415
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Development of Stable and Simple Finasteride 333-μg/mL Suspensions that Minimize Occupational Exposure Ma Nathan, Perks William, Law Shirley, Iazzetta John, Walker Scott	Nov/Dec 2020 Pg. 519-527
Containment of Hazardous Particulates in the Compounding Pharmacy Allen Loyd V Jr	Jul/Aug 2003 Pg. 281-285
PreScription: Permissible Exposure Limits and United States Pharmacopeia Chapter <800> Allen Loyd V Jr	Sep/Oct 2021 Pg. 356
Current Topical Treatments in Wound Healing - Part 1 Helmke Christopher D	Jul/Aug 2004 Pg. 269-274
Minimizing the Risk of Cholesterol-Lowering Therapy Pratt Sam	Sep/Oct 2001 Pg. 362-364
Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs Harrington Catherine A, Cauffield Jacintha	May/Jun 2005 Pg. 201-205
Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States Lobb William B, Wilkin Noel E, Holmes Erin R	Nov/Dec 2015 Pg. 514-520
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA Cabaleiro Joe	Sep/Oct 2021 Pg. 358-362
Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser Christiansen Joel, White Lyndell	Jul/Aug 2010 Pg. 310-314
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III	May/Jun 2010 Pg. 182-192
Patient-centered Care as Value-added Service by Compounding Pharmacists McPherson Timothy B, Fontane Patrick E, Day Jonathan R	Jul/Aug 2013 Pg. 339-343
Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding Soefje Scott, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P	Nov/Dec 2021 Pg. 515-522
Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint) Soefje Scott, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P	Jan/Feb 2022 Pg. 72-79
Determination of Risk for Sterile Preparations Freedman ben-Horin Shimon, Rousso Tamaro	Jan/Feb 2014 Pg. 30-34
Legislative/Regulatory Update: From the International Academy of Compounding Pharmacists: Appropriations McCrory Gary	Mar/Apr 2016 Pg. 95-96
Patient Satisfaction with Pharmacist Intervention and Consultation in HRT DiMaggio Jennifer Lyn, Reed-Kane Dana	Jul/Aug 2003 Pg. 258-263
Compounding with Controlled Substances Whalen Mary Kate	Jan/Feb 2002 Pg. 8-10
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc	Jan/Feb 2014 Pg. 6-12
Return to Top